Introduction {#Sec1}
============

Catheter-based cryoablation (cryo) has proven to be an effective, safe and versatile tool for arrhythmia treatment. Despite several advantages, it still requires relatively long procedure times compared to radiofrequency energy (RF) catheter ablation. Historically, lesion formation during cryo is subject to several factors including cooling temperature \[[@CR1]\], application duration, repetition of an application \[[@CR2]\] and convective heating \[[@CR3], [@CR4]\], the combination of which can considerably prolong procedure time. We have shown that a high efficacy can be maintained when single instead of repeated freeze thaw cycles are used, which results in a significant reduction of the procedure time \[[@CR5]\]. Other studies have shown that typical atrial flutter (AFL) can be effectively treated when the duration of a cryoapplication is reduced from 5 to 2 min \[[@CR6]--[@CR9]\]. However, it is unknown if procedural and long-term efficacy remain unaffected if short cryoapplication times (similar to RF) are used. Biomedical engineering has enabled deeper cooling temperatures and catheter refinements that allow for a reduction of the application duration. Other factors like contact pressure, catheter-tip orientation and tip-size also play an important role in cryo \[[@CR10], [@CR11]\]. These developments in cryotechnology may have rendered short application times effective. The purpose of the current study was to prospectively evaluate the acute and long-term efficacy of cryo for AFL using single 1-min applications.

Patients and methods {#Sec2}
====================

Patients {#Sec3}
--------

Thirty-seven consecutive patients (28 men; mean age of 59 ± 14, range 18 years to 78 years) were included. In 23 patients the AFL burden could be assessed. This burden of clinical AFL was documented for a median of 8 months, ranging from 1 month to 105 months. Ten patients required two or more cardioversions at the emergency department. In the remaining 14 patients total AFL burden could not be determined.

The study was approved by the hospital ethics committee and informed consent was obtained from all patients for both the index-procedure and a repeat electrophysiological study scheduled 4 months after the index-procedure**.** The demographic characteristics of the patients are shown in Table [1](#Tab1){ref-type="table"}. Twenty-four patients (65%) also had a history of atrial fibrillation. In four of these patients (17%) atrial fibrillation organised into AFL during treatment with class 1C anti-arrhythmic drugs (AAD). Table 1DemographicsPatients37Age, years59 ± 14Sex, M/F28/9Structural heart disease, n24Hypertensive10Ischemic4Dilated3Valvular1Hypertensive/ischemic3Hypertensive/Dilated2Hypertensive/Valvular1Mean left ventricular ejection fraction ,%54 ± 15Mean left atrial size, mm45 ± 7Concomitant atrial fibrillation, n24Pacemaker/ICD, n4/2IC AFL, n4Class III AAD (amiodaron/sotalol/both), n6/10/1Other AAD, n16*n* number of patients; *AAD* anti-arrhythmic drugs; *IC AFL* organisation of atrial fibrillation to atrial flutter during; treatment with IC anti-arrhythmic drugs; *ICD* intracardiac defibrillator

Ablation procedure {#Sec4}
------------------

The ablation procedure was performed according to a technique previously defined \[[@CR7]\]. AAD were not discontinued before the procedure. All patients were studied in the fasting state under local anaesthesia. Intravenous heparin was given as a 100 IU/kg bolus dose directly after insertion of the venous sheaths, and the activated clotting time was kept at 300--350 sec by additional heparin bolus throughout the remainder of the procedure.

Three multipolar catheters were advanced in the right atrium through insertion of a femoral vein. One 20-pole electrode catheter (2-mm interelectrode spacing, Halo catheter, Biosense Webster, Diamond Bar, CA, USA) was positioned around the tricuspid annulus for sequential activation mapping. A quadripolar catheter and a decapolar catheter were placed at the His-bundle and in the coronary sinus respectively. Cryo was performed using the CryoCor™ Cardiac Cryoablation System \[[@CR7]\]. A steerable 10-French bipolar catheter with a 10-mm tip was used in combination with a long venous sheath (St Jude Medical, SL2; 12F; Daig Co, Minnetonka, MN, USA) for mapping and ablation of the cavotricuspid isthmus (CTI). After initial fluoroscopic positioning of the ablation catheter at the CTI, all subsequent repositioning was done with the aid of anatomic (fluoroscopic) and electrophysiological guidance. The 12-lead ECG and intracardiac electrograms were recorded and stored by the BARD Labsystem Pro. Electrograms were analyzed at a gain setting of 0.1 to 0.2 mV/cm and at a sweep speed of 100--200 mm/s. Entrainment to confirm isthmus dependency of the AFL circuit was performed in patients with only AFL and in patients with AFL and a few episodes of atrial fibrillation. In patients with AFL and frequent atrial fibrillation episodes, entrainment was not performed to avoid induction of atrial fibrillation. If atrial fibrillation was present an attempt was made to regain sinus rhythm by means of flecainide infusion and/or internal or external cardioversion. Both catheter-tip temperature and system pressure were monitored throughout the procedure to ensure consistent catheter-tip energy delivery. Linear lesions were created at a target temperature of −90 °C, using single 1-min cryoapplications in a ventriculo-atrial fashion, starting at the tricuspid annulus edge. If a complete line of block was not achieved within 12 1-min applications, additional 3-min applications were used. This cut-off value was used based on our previous experience with an 8-mm tipped RF catheter where a mean of 12 applications were necessary to obtain CTI block \[[@CR12]\]. After documentation of bidirectional isthmus conduction block, incremental atrial pacing from the proximal coronary sinus was performed without and with isoproterenol infusion (1--3 µg/min) to induce AFL. Thirty minutes were taken to monitor CTI reconduction after CTI block was obtained. On the resumption of CTI conduction, further cryoapplications were delivered until complete block was obtained again, whereafter another 30-min observation was used to confirm CTI block. As stated above, a maximum of 12 1-min applications (including all applications prior to isoproterenol infusion) were allowed to meet procedural endpoints. Thereafter, 3-min applications were used.

Procedural endpoints were the assessment of bidirectional CTI block and non-inducibility of AFL. Procedure time was defined as the time interval between the first femoral vein puncture for catheter insertion and the last cryoapplication.

Post-ablation management {#Sec5}
------------------------

A 24-h Holter monitor was given immediately after the procedure until hospital discharge and thereafter, if symptoms suggested an arrhythmia recurrence**.** Only in patients with pre-existing atrial fibrillation, AAD were continued after the ablation procedure. Oral anticoagulation was started the day of the ablation. After 3 months the necessity for long-term anticoagulation was reassessed by the number of AFL/atrial fibrillation recurrences and the presence of risk factors for thromboembolic complications. Patients living in the region of Maastricht were followed-up at our outpatient clinic at 1- and, thereafter, every 3 months. For patients, from outside this region, follow-up was obtained by the referring Cardiologist. In case of documentation of AFL, the patient was again referred to our hospital for further evaluation and re-ablation**.** All patients were instructed to contact our center or the nearest hospital if they had any symptoms (e.g. palpitations, chest discomfort) which could indicate a recurrence. Electrophysiological re-evaluation was performed either after 4 months and/or if there was a recurrence of AFL. In case of resumption of isthmus conduction a second ablation was performed using 1-min applications at areas of conduction breakthrough in an attempt to regain complete bidirectional CTI block. The electrograms were observed from the ablation catheter-tip just before the delivery of energy. The amplitude of the atrial and ventricular component was used for gap localisation along the CTI (ventricle, atrioventricular groove, atrium and atrium-inferior vena cava transition). Conduction times measured during the electrophysiological re-evaluation were not compared directly to those obtained during the index-procedure, since identical electrode positions could not be guaranteed.

Statistical analysis {#Sec6}
--------------------

All data are expressed in mean ± SD or median and range. To compare baseline characteristics between patients with persistent CTI block and those with CTI reconduction an unpaired *t-*test was used for continuous variables and the chi-square (or Fisher's exact) test for categorical variables. When normality and equal variance analyses failed, a Mann-Whitney rank sum test was used instead of an unpaired *t-*test. For differences between patients with persistent CTI block, CTI reconduction and undetermined CTI conduction (no repeat electrophysiological study) a Kruskal-Wallis test was used for continuous variables and the chi-square test for categorical variables. The significance level was set at *p* \< 0.05.

Results {#Sec7}
=======

Details of the electrophysiological study and cryo procedure are summarized in Table [2](#Tab2){ref-type="table"}. All patients had a documented typical AFL. In one patient an overextended cryoablation catheter necessitated the use of RF ablation to complete the procedure. This patient was excluded from further analysis. In another patient an abnormal atrial anatomy prevented adequate cannulation of the coronary sinus prolonging fluoroscopy time. In this patient 11 1-min applications were delivered to observe isthmus conduction delay before the procedure was prematurely terminated. This patient did not show any AFL recurrence during 40 months of follow-up. Table 2Electrophysiological characteristics of the index-procedureAFL, CCW/CW34/3Cycle length, ms252 ± 44Patients requiring cardioversion,8Chemical, and3Electrical8Successful 1-min-application, n31/36 (86%)Number of 1-min-applications7 ± 2Temperature, °C−88 ± 2Fluoroscopy time, min27 ± 14Procedure time, min110 ± 28Acute success, n35/36 (97%)Recurrence AFL, n2/36 (6%)*AFL* atrial flutter; *CCW* counterclockwise; *CW* clockwise; *n* number of patients

The median number of 1-min freezes needed to obtain the procedural endpoints was 7 (range 3--12). Five patients (14%) required additional 3-min applications (median 2, range 2--5). The average temperature during 1-min cryodelivery was −88.6 ± 2.3 (range −83 to −93) °C and the mean nadir temperature was −89.0 ± 2.3 (rang −85 to −93) °C. Isoproterenol infusion was used in all but three patients, in whom repeated bouts of atrial fibrillation already occurred during atrial pacing. Nine patients (25%) showed recovery of isthmus conduction during isoproterenol infusion. In all patients bidirectional CTI block could be re-established after a median of two 1-min applications (range 1--3; eight patients), and two 3-min applications. No additional applications were required during a second observation period.

Cardioversion of atrial fibrillation was performed in eight patients. Sinus rhythm was obtained by internal cardioversion (*n* = 2), external cardioversion (*n* = 3), or intravenous administration of flecainide followed by external cardioversion (*n* = 3). Mean fluoroscopy and procedure time were 27 ± 14 (range 8 to 58) and 110 ± 28 (range 61 to 180) minutes respectively.

Follow-up {#Sec8}
---------

After a mean follow-up of 37 ± 3 (range 30 to 44) months, a recurrence of AFL was registered in only two patients (6%), 2 months and 3 months after the index-procedure respectively. Eleven patients declined a repeated electrophysiological study, despite previous informed consent and one patient died of a non-cardiac cause 2 months after the index-procedure. A total of 24 patients underwent a repeated electrophysiological study including both patients with AFL recurrence. In these two patients, the arrhythmia terminated after one and two 1-min cryoapplications at the atrioventricular groove. Complete bidirectional CTI block was seen in 12 patients (50%) even though significant fewer cryoapplications were used at the index-procedure compared to those patients that showed resumption of CTI conduction (*P* = 0.004; Table [3](#Tab3){ref-type="table"}). Furthermore, no 3-min applications were required during the index-procedure for those patients who underwent a repeat electrophysiological study. Table 3Baseline characteristics of CTI conduction propertiesRepeat EPSNo Repeat EPSCTI blockCTI conductionUndeterminedPatients121212Age, years56 ± 18 (18--78)63 ± 10 (51--77)57 ± 12 (25--71)Concomitant AF, n7107LA size, mm45 ± 10 (29--63)43 ± 3 (38--47)46 ± 9 (30--58)AFL, CCW/CW10/212/011/1AFL cycle length, ms261 ± 54 (190--328)251 ± 59 (180--360)245 ± 30 (200--300)Total number of successful 1-mincryoapplications6 ± 2 (3--8)\*^,^\*\*8 ± 2 (5--12)8 ± 4 (4--12)Additional 3-min applications, n0\*\*05Reconduction during isoprotenerol, n6\*\*21Temperature, ºC−86 ± 2 (−81--−90)−87 ± 3 (−83--−94)−87 ± 1 (−85--−88)Fluoroscopy time, min21 ± 12 (8--54)\*^,^\*\*26 ± 6 (16--43)39 ± 20 (11--78)Procedure time, min99 ± 22 (67--134)110 ± 24 (73--145)119 ± 42 (61--180)Acute success, n (%)12 (100)12 (100)11 (92)Recurrence AFL, n (%)0\*\*2 (17)0Follow-up, months38 ± 4 (30--41)38 ± 5 (31--47)36 ± 4 (30--41)*EPS* electrophysiological study; *AF* atrial fibrillation; *n* number of patients; *LA* left atrium; *AFL* atrial flutter; *CCW* counterclockwise; *CW* clockwise\**P* \< 0.05 compared to patients with CTI conduction, \*\**P* \< 0.05 compared to patients with or undetermined CTI conduction

In the majority of patients in whom isthmus reconduction was observed, gaps were found at the atrioventricular groove (58%). Details concerning their second ablation procedure are depicted in Table [4](#Tab4){ref-type="table"}. AFL occurred in four patients: in two patients AFL recurred (as mentioned above) and in the other two patients AFL was induced with incremental atrial pacing. Procedural endpoints were met in all patients after a median of one 1-min application (range 1--3) without the need of additional applications after isoproterenol infusion. The patients did not report any discomfort during cryodelivery \[[@CR13]\]. No complications were seen, including groin hematomas or pseudo-aneurism formation despite the large diameter of the sheath used. Table 4Electrophysiological and ablation characteristics of patients with CTI conduction recovery123456789101112Index procedure Pre-ablation AADamioflecamioBBflecdyssotamiosotflecsotsot LA size, mm434241463841454342474142 Concomitant arrhythmiasATAFAF/VTAFAFAFAFAFAFCMT/ATAFAF AFL, CCW/CWCCWCCWCCWCCWCCWCCWCCWCCWCCWCCWCCWCCW Cycle length, ms266240320220300240220220200360220180 Conduction recovery during isoprenalinenoyes--^a^yesnononononononono Successful 1-min-applications96124871159798 Additional applications 1-min/3-min--2/0--3/0----------------Repeat procedure Recurrence AFLyesnononoyesnonononononono Pre-ablation AADsotflecamioBBflecdyssotnonesotflecsotsot AFL inductionnonoyesnononononononoyesno Location terminal applications/gapsAVVCAVAVVCAVVCVCAVAVAAV Conduction recovery during isoprenalinenono--^a^nonononononononono Successful 1-min-applications321211111122See text for more details^a^no isoprenaline infusion, because of repeated bouts of atrial fibrillation during atrial pacing*AAD* anti-arrhythmic drugs; *amio* amiodarone; *flec* flecainide; *BB* beta-blocker; *dys* dysopyramide; *sot* sotalol; *LA* left atrium; *AFL* atrial flutter; *CMT* circus movement tachycardia; *AT* atrial tachycardia; *CCW* counter-clock wise; *CW* clockwise; *AV* atrioventricular groove; *A* atrial tissue between the atrioventricular groove and inferior caval vein, *VC* atrium-inferior caval vein transition

Of the 24 patients with atrial fibrillation prior to the procedure, six patients (25 %) underwent additional pulmonary vein isolation during follow-up because of recurrent symptomatic episodes.

Discussion {#Sec9}
==========

Major findings {#Sec10}
--------------

The present study demonstrates that a reduction in application duration as low as 1 min is feasible during cryo of AFL, resulting in shorter procedure times compared to previous cryoablation protocols \[[@CR5]--[@CR8]\], while maintaining similar clinical efficacy. Although a substantial number of patients revealed resumption of CTI conduction 4 months after cryo, AFL recurred in only two patients (6%).

Refinements in cryothermia: Cryo vs. cryo {#Sec11}
-----------------------------------------

As opposed to early catheter development using smaller catheter-tips and higher nadir temperatures \[[@CR6], [@CR8], [@CR9], [@CR14]\], current equipment presented herein enables large lesion formation reflected by stable CTI conduction block at the minimum duration of cryodelivery. Applications were delivered using a 10-F, 10-mm catheter-tip at a mean temperature of −88.6°C the combination of which allowed a decrease in the duration of cryodelivery as low as 1 min per application per site. Lesion formation during cryothermia is a complex process involving the synergetic effects of the initiated expanding cold front during freezing and its anticipated thawing. As a result shifts in membrane permeability and osmotic state inflict irreversible cell damage by massive intracellular swelling ultimately leading to membrane disruption and loss of cell integrity. Ablation temperatures beyond −50°C are known to cause irreversible tissue damage \[[@CR15]\] and may enhance passive conduction to deeper myocardial layers. Deep cooling temperatures may also delay total thaw duration augmenting the deleterious effects of affected frozen cells. In addition, contraction of surrounding (micro) vessels as tissue temperature decreases may further add to cell decay \[[@CR15]\]. Cryo at mean tip-temperatures of −88.6°C obtained in our study have not been previously reported and may have an advantage regarding the abovementioned cumulative effects.

The repetition of a cryoapplication supported by evidence from cryosurgery \[[@CR2], [@CR16]\] has long been advocated for percutaneous applications, since it is known to enhance tissue injury. This may be because previously damaged cell structures act as a synctitium to facilitate thermal conductivity of the following cold front thereby allowing deep penetration and subsequently more tissue loss \[[@CR2]\]. In conjunction with recent reports \[[@CR6], [@CR8], [@CR14]\], our study supports the reduction in number of applications per site during transvenous cryodelivery either being the result of site specific cryoredundancy or differences in biophysics compared to its extra-luminal counterpart.

Contrary to 1 min of single cryodelivery used in this study, ablation protocols from previous studies used at least 2 min per application and allowed an increase in application time up to 5 min to obtain acute and long-lasting success \[[@CR6], [@CR8], [@CR9], [@CR14]\]. Furthermore, the number of applications necessary to maintain CTI block used in these studies was similar compared to our study indicating equal lesion formation. Counterintuitively, in our study patients with stable CTI block required significant fewer applications compared to patients that showed conduction recovery, suggesting that other factors like CTI anatomy (eg. pouch-like configuration) \[[@CR17]\] and catheter-tip orientation may also be important. In an experimental model, Tse et al \[[@CR18]\] favoured the use of long application times, repetition of applications and horizontal positioning of the catheter-tip in order to gain maximal tissue injury. Even at maximum target temperatures of approximately −78°C obtained by single 2.5-min applications in combination with a 6.5-mm catheter-tip, lesion geometry could be sufficient to override CTI dimensions \[[@CR19]\] thus prohibiting excess cryodelivery and its attendant delay in procedure time.

CTI conduction recovery {#Sec12}
-----------------------

In the current study, a large proportion of patients showed isthmus reconduction, without a recurrence of AFL. Resumption of CTI conduction is not infrequently seen, but only a few studies systematically re-evaluated CTI conduction. While complete CTI block is associated with a high long-term success, most studies have focussed on AFL recurrences, withholding possible conduction recovery incapable of AFL re-initiation. Anselme et al \[[@CR20]\] reported conduction recovery in up to 45% of patients (18/40) treated with RF 1 month after the index-procedure. The recurrence of AFL was low, though might have been obscured at early re-evaluation where wound healing may still be in progress. Schumacher et al \[[@CR21]\] performed a repeat electrophysiological study in 38/41 patients one year after RF ablation. The authors used non-inducibility of AFL regardless of CTI block as the primary endpoint. Only 2/22 patients experienced AFL recurrence after previous confirmation of bidirectional CTI block, contrary to the 7/13 and 6/6 patients with either unidirectional block or only ≥10 ms CTI delay respectively. This high incidence of AFL recurrence may be due to differences in primary endpoints and the lack of isoproterenol infusion \[[@CR22]\] during the observation period, which proved effective in 25% of our patients. Montenero et al \[[@CR14]\] reported a CTI recovery rate of 31%, 3 months after treatment with cryo. While the authors considered this as a possible reservoir for AFL re-initiation, no AFL recurrence was reported during 9 months of follow-up. These data confirm that CTI conduction recovery does not necessarily imply AFL recurrence and that CTI block after 3 months likely precludes future recovery. In our study population, two patients without recurrent AFL were susceptible to AFL induction, suggesting a higher recurrence rate than we described. One cannot exclude the possibility that the high CTI reconduction rate was due to the short cryoapplication time. Moreover, early re-ablation could in part have prevented future AFL from re-occurring, thereby masquerading a higher AFL recurrence rate. On the other hand, no resumption of AFL was found during substantial long-term follow-up even though 30% of patients declined re-evaluation. This may indicate either stable CTI block or sufficient CTI delay to prevent maintenance of a reentry circuit in the right atrium. Deprived blood supply and differences in cell-to-cell (mal) orientation \[[@CR23]\] may have altered conduction properties of the remaining viable cells and subsequently their critical coupling necessary for the development of AFL. The abovementioned effects may have also increased the action potential duration of embedded viable cells thereby influencing their susceptibility and dose-response to AAD \[[@CR24], [@CR25]\]. In addition, one may hypothesize that some patients with sufficient CTI delay may have had at least in part AF secondary to degeneration of AFL, thereby decreasing the amount of reinitiated AFL \[[@CR26]\].

Gaps were mainly found at the level of the tricuspid valve ridge emphasizing the need for adequate catheter alignment to the underlying tissue to obtain maximum lesion size. Although cryoadherence facilitates catheter stability during freezing initial positioning prior to delivery remains vital. The pouch-like configuration of the isthmus may hamper an optimal tip-tissue interface necessary to obtain sufficient injury of deeper myocardial layers. Possibly longer applications or repeated ones are required in this region to prevent future recurrences.

Cryoablation vs. RF ablation {#Sec13}
----------------------------

By lowering single freeze duration in conjunction with a 10-mm catheter-tip, the procedure time was comparable to the procedure time obtained by conventional RF ablation using 4-mm or 8-mm catheter-tips \[[@CR12], [@CR13], [@CR27]\]. Shorter RF ablation times have been reported when using a maximal voltage-guided approach. One has to consider that procedure time is not always adequately defined and a 30-min waiting period is not uniformly included.

In addition, the mean number of applications necessary to obtain bidirectional CTI block was not different from that required during conventional RF delivery \[[@CR21]\]. Fluoroscopy time was also comparable to RF, suggesting a similar time span for catheter handling \[[@CR27]\]. More importantly, these parameters could be adjusted to RF standards without compromising acute (97%) and long-term (94%) efficacy.

Study limitations {#Sec14}
-----------------

The current study was conducted in a small group of patients. Only two-thirds of the study population agreed to undergo re-evaluation, which may have biased the observed CTI conduction recovery and its relation to AFL recurrences. As in most studies reporting on long-term efficacy of AFL, follow-up was mainly based on symptoms. Therefore, we cannot exclude a higher recurrence rate due to asymptomatic episodes of AFL.

Conclusions {#Sec15}
===========

Cryo of AFL can successfully be performed with 1-min applications, using a 10-mm catheter-tip, resulting in short procedure times. Both acute and long-term results are comparable to RF ablation. A high CTI reconduction rate was observed at follow-up but was not associated with a similar degree of AFL recurrences. The clinical relevance of this finding could not be answered by this study.
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